Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

MYC positive

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

MYC overexpression (18)

MYC expression (9)

BCL2 expression + MYC expression (8)

MYC overexpression + BCL2 overexpression (7)

MYC expression + BCL2 expression (2)

MYC underexpression (2)

miR-17-HG overexpression + MYC positive (2)

BCL2 overexpression + MYC overexpression (1)

BTK expression + BCL2 expression + MYC expression (1)

BTK expression + MYC expression (1)

CHEK1 overexpression + MYC overexpression (1)

MYC expression + BCL2 expression + BCL6 expression (1)

MYC expression + MCL1 expression (1)

MYC negative (1)

MYC positive + BCL2 positive (1)

MYC positive + BCL2 positive + BCL6 positive (1)

MYC expression + PAICS expression (1)

OTUD6B expression + MYC expression (1)

miR-17-HG expression + MYC positive (1)

MYC overexpression (18)

MYC expression (9)

BCL2 expression + MYC expression (8)

MYC overexpression + BCL2 overexpression (7)

MYC expression + BCL2 expression (2)

MYC underexpression (2)

miR-17-HG overexpression + MYC positive (2)

BCL2 overexpression + MYC overexpression (1)

BTK expression + BCL2 expression + MYC expression (1)

BTK expression + MYC expression (1)

CHEK1 overexpression + MYC overexpression (1)

MYC expression + BCL2 expression + BCL6 expression (1)

MYC expression + MCL1 expression (1)

MYC negative (1)

MYC positive + BCL2 positive (1)

MYC positive + BCL2 positive + BCL6 positive (1)

MYC expression + PAICS expression (1)

OTUD6B expression + MYC expression (1)

miR-17-HG expression + MYC positive (1)

›

MYC positive	Diffuse Large B Cell Lymphoma	MYC positive	Diffuse Large B Cell Lymphoma	tisagenlecleucel-T Sensitive: C3 – Early Trials tisagenlecleucel-T Sensitive : C3	tisagenlecleucel-T Sensitive: C3 – Early Trials tisagenlecleucel-T Sensitive : C3
MYC positive	Non-Hodgkin’s Lymphoma	MYC positive	Non-Hodgkin’s Lymphoma	Resistant: C3 – Early Trials Resistant : C3	Resistant: C3 – Early Trials Resistant : C3
MYC positive	Diffuse Large B Cell Lymphoma	MYC positive	Diffuse Large B Cell Lymphoma	pixantrone Sensitive: C3 – Early Trials pixantrone Sensitive : C3	pixantrone Sensitive: C3 – Early Trials pixantrone Sensitive : C3